Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients

Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients

The recent spreading of new SARS-CoV-2 variants, carrying several mutations in the spike protein, could impact immune protection elicited by natural infection or conferred by vaccination. In this study, we evaluated the neutralizing activity against the viral variants that emerged in the United King...

Full description

Bibliographic Details
Main Authors: Claudia Maria Trombetta, Serena Marchi, Simonetta Viviani, Alessandro Manenti, Linda Benincasa, Antonella Ruello, Emilio Bombardieri, Ilaria Vicenti, Maurizio Zazzi, Emanuele Montomoli
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Viruses
Subjects:
neutralizing activity
SARS-CoV-2
variants of concern
Online Access:https://www.mdpi.com/1999-4915/13/7/1347

Internet

https://www.mdpi.com/1999-4915/13/7/1347

Similar Items